[1]
Maneesuwansin,, S., Suk-ouichai, C., Ramart, P., Jitpraphai, S., Phinthusophon, K., Chotikawanich, E., Amornvesukit, T., Taweemonkongsap, T., Chaiyaprasithi, B., Leewansangtong, S., Srinualnad, S. and Nualyong, C. 2019. Administration of Renin-Angiotensin System Inhibitor Affects Tumor Recurrence and Progression in Non-Muscle Invasive Bladder Cancer Patients. Siriraj Medical Journal. 71, 1 (Feb. 2019), 31–37. DOI:https://doi.org/10.33192/Smj.2019.06.